Fox Run Management L.L.C. Takes Position in Cognex Corporation $CGNX

Key Points

• Fox Run Management L.L.C. acquired 41,654 shares of Cognex Corporation (NASDAQ:CGNX) valued at approximately $1.24 million.
• Several institutional investors have increased their stakes in Cognex, resulting in institutional ownership rising to 88.12% of the company's stock.
• Cognex announced a quarterly dividend of $0.08 per share, with a yield of 0.7%, which will be paid on August 28th.

Fox Run Management L.L.C. bought a new position in Cognex Corporation (NASDAQ:CGNX - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 41,654 shares of the scientific and technical instruments company's stock, valued at approximately $1,243,000.

Several other large investors have also made changes to their positions in the company. Mackenzie Financial Corp grew its holdings in shares of Cognex by 126.2% in the 1st quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock worth $137,510,000 after purchasing an additional 2,571,457 shares during the last quarter. Lazard Asset Management LLC increased its stake in shares of Cognex by 1.1% in the fourth quarter. Lazard Asset Management LLC now owns 2,256,640 shares of the scientific and technical instruments company's stock valued at $80,923,000 after buying an additional 25,492 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Cognex by 1.9% in the first quarter. Bank of New York Mellon Corp now owns 2,131,538 shares of the scientific and technical instruments company's stock valued at $63,584,000 after buying an additional 38,857 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Cognex by 6.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,902,930 shares of the scientific and technical instruments company's stock valued at $68,239,000 after buying an additional 117,089 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Cognex by 35.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,891,602 shares of the scientific and technical instruments company's stock valued at $67,834,000 after buying an additional 497,341 shares in the last quarter. Institutional investors own 88.12% of the company's stock.

Cognex Stock Performance

CGNX traded up $0.3540 during midday trading on Tuesday, reaching $43.3640. 1,140,958 shares of the company were exchanged, compared to its average volume of 2,107,078. Cognex Corporation has a one year low of $22.67 and a one year high of $44.38. The stock has a market capitalization of $7.28 billion, a P/E ratio of 61.12 and a beta of 1.47. The stock's 50-day simple moving average is $34.84 and its 200 day simple moving average is $31.91.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The firm had revenue of $249.09 million for the quarter, compared to analysts' expectations of $246.70 million. During the same quarter last year, the business earned $0.23 earnings per share. The company's revenue was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, research analysts anticipate that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th will be issued a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, August 14th. Cognex's payout ratio is 45.07%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CGNX. UBS Group raised their target price on Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a research note on Friday, August 1st. KeyCorp upgraded Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 target price for the company in a research note on Friday, August 1st. Melius upgraded Cognex from a "hold" rating to a "buy" rating and set a $60.00 target price for the company in a research note on Thursday, July 10th. Needham & Company LLC raised their target price on Cognex from $36.00 to $45.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Finally, Robert W. Baird lifted their price objective on Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research report on Monday, June 16th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Cognex currently has an average rating of "Moderate Buy" and a consensus target price of $42.31.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.